Endurant Capital Management’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $156K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $679K | Buy |
|
|||||
|
2021
Q4 | – | Sell |
|
|||||
|
2021
Q3 | $1.21M | Sell |
|
|||||
|
2021
Q2 | $2.1M | Sell |
|
|||||
|
2021
Q1 | $11.5M | Sell |
|
|||||
|
2020
Q4 | $7.29M | Sell |
|
|||||
|
2020
Q3 | $3.68M | Sell |
|
|||||
|
2020
Q2 | $2.8M | Sell |
|
|||||
|
2020
Q1 | $2.72M | Buy |
|
|||||
|
2019
Q4 | $3.88M | Buy |
|
|||||
|
2019
Q3 | $1.91M | Buy |
|
|||||
|
2019
Q2 | $3.57M | Buy |
|
|||||
|
2019
Q1 | $3.27M | Buy |
|